Literature DB >> 3708956

Diffuse muscle fiber atrophy in newly diagnosed diabetes.

J Jakobsen, E Reske-Nielsen.   

Abstract

Muscle fiber dimensions were studied in six newly diagnosed insulin-dependent young diabetic males and in four age, sex and weight matched controls. Three of the patients had never received any antidiabetic medication before biopsy and the others had been treated with insulin for a few days only. Mean fiber caliber of the anterior tibial muscle was smaller in diabetics than in controls, the values being 61.8 +/- 4.3 micron (SD) versus 77.8 +/- 9.1 micron (2p less than 0.01). The size-frequency distribution of fiber calibers showed that a considerable part of the fiber population was reduced in size. No significant changes were found in sarcomere length, number of muscle or interstitial cell nuclei or number of capillaries. The observation of an over-all reduction of muscle fiber size following a few weeks of severe hyperglycemia is in accordance with previous experimental studies. We conclude that the catabolism associated with a sustained and uncorrected diabetic state in man leads to muscle fiber atrophy.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3708956

Source DB:  PubMed          Journal:  Clin Neuropathol        ISSN: 0722-5091            Impact factor:   1.368


  13 in total

Review 1.  Diabetes pharmacotherapy and effects on the musculoskeletal system.

Authors:  Evangelia Kalaitzoglou; John L Fowlkes; Iuliana Popescu; Kathryn M Thrailkill
Journal:  Diabetes Metab Res Rev       Date:  2018-12-20       Impact factor: 4.876

2.  Low-frequency stimulation regulates metabolic gene expression in paralyzed muscle.

Authors:  Michael Petrie; Manish Suneja; Richard K Shields
Journal:  J Appl Physiol (1985)       Date:  2015-01-29

Review 3.  Differential control of muscle mass in type 1 and type 2 diabetes mellitus.

Authors:  David Sala; Antonio Zorzano
Journal:  Cell Mol Life Sci       Date:  2015-06-20       Impact factor: 9.261

4.  Impaired growth and force production in skeletal muscles of young partially pancreatectomized rats: a model of adolescent type 1 diabetic myopathy?

Authors:  Carly S Gordon; Antonio S Serino; Matthew P Krause; Jonathan E Campbell; Enzo Cafarelli; Olasunkanmi A J Adegoke; Thomas J Hawke; Michael C Riddell
Journal:  PLoS One       Date:  2010-11-17       Impact factor: 3.240

Review 5.  Skeletal muscle as a therapeutic target for delaying type 1 diabetic complications.

Authors:  Samantha K Coleman; Irena A Rebalka; Donna M D'Souza; Thomas J Hawke
Journal:  World J Diabetes       Date:  2015-12-10

6.  Autophagy-regulating TP53INP2 mediates muscle wasting and is repressed in diabetes.

Authors:  David Sala; Saška Ivanova; Natàlia Plana; Vicent Ribas; Jordi Duran; Daniel Bach; Saadet Turkseven; Martine Laville; Hubert Vidal; Monika Karczewska-Kupczewska; Irina Kowalska; Marek Straczkowski; Xavier Testar; Manuel Palacín; Marco Sandri; Antonio L Serrano; Antonio Zorzano
Journal:  J Clin Invest       Date:  2014-04-08       Impact factor: 14.808

7.  Inhibition of plasminogen activator inhibitor-1 restores skeletal muscle regeneration in untreated type 1 diabetic mice.

Authors:  Matthew P Krause; Jasmin Moradi; Aliyah A Nissar; Michael C Riddell; Thomas J Hawke
Journal:  Diabetes       Date:  2011-05-18       Impact factor: 9.461

8.  Impaired macrophage and satellite cell infiltration occurs in a muscle-specific fashion following injury in diabetic skeletal muscle.

Authors:  Matthew P Krause; Dhuha Al-Sajee; Donna M D'Souza; Irena A Rebalka; Jasmin Moradi; Michael C Riddell; Thomas J Hawke
Journal:  PLoS One       Date:  2013-08-12       Impact factor: 3.240

9.  A soluble activin receptor type IIB does not improve blood glucose in streptozotocin-treated mice.

Authors:  Qian Wang; Tingqing Guo; Jennifer Portas; Alexandra C McPherron
Journal:  Int J Biol Sci       Date:  2015-01-05       Impact factor: 6.580

10.  Statin Therapy Alters Lipid Storage in Diabetic Skeletal Muscle.

Authors:  Irena A Rebalka; Matthew J Raleigh; Laelie A Snook; Alexandra N Rebalka; Rebecca E K MacPherson; David C Wright; Jonathan D Schertzer; Thomas J Hawke
Journal:  Front Endocrinol (Lausanne)       Date:  2016-07-19       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.